CTOs on the Move

Thorek Memorial Hospital

www.thorek.org

 
Thorek Memorial Hospital is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Thorek Memorial Hospital is based in Chicago, IL. You can find more information on Thorek Memorial Hospital at www.thorek.org
  • Number of Employees: 250-1000
  • Annual Revenue: $100-250 Million
  • www.thorek.org
  • 850 W Irving Park Rd
    Chicago, IL USA 60613
  • Phone: 773.525.6780

Executives

Name Title Contact Details

Similar Companies

Esoterix

Esoterix Inc. is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Esoterix Inc. is based in Austin, TX. You can find more information on Esoterix Inc. at www.esoterix.com

Eurotech Tables/Manufacturing

Eurotech Tables/Manufacturing is a Osage Beach, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Centric Health

Centric Health`s vision is to be Canada`s premier healthcare company, providing innovative solutions centered on patients and healthcare professionals.

Sentage Corporation

Sentage Corporation is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Mela Sciences

At MELA Sciences, we design and develop innovative software-driven medical technologies for physician clinical use during the detection of skin cancers at the most curable and cost-effective stages. Our mission is to develop breakthrough medical technologies to improve skin cancer detection and achieve better outcomes for all. We envision a world in which our pioneering innovations will change the way patients think about skin cancer, while providing dermatologists and clinicians with new, effective, non-invasive tools for the earliest detection possible. MELA Sciences conducted the largest, positive prospective study ever done on the melanoma disease, and is the first and only medical technology company to receive both FDA Pre-Market Approval (PMA) for the U.S. and CE Marking certification for the European Union for a device of this nature. The company’s flagship product, MelaFind®, is intended to provide dermatologists with software-driven image analysis of clinically atypical pigmented skin lesions when they choose to obtain additional information to help decide whether to biopsy or not. The FDA has approved MELA Sciences’ MelaFind® Pre-Market Approval application for use in the United States and MELA Sciences has also been granted CE Mark approval for sale of MelaFind® in the European Union.